Enzyme-catalyzed reactions are important to regulate steroidogenesis and nuclear receptor activation. The present investigation examines the role of steroid metabolism catalyzed by CYP7B1 for regulation of hormone receptor activation and the effects of vitamin D on enzymatic regulation of steroidogenesis. The study reports data indicating that CYP7B1 can regulate estrogenic signaling by converting estrogens into inactive or less active metabolites. Similar results were obtained for CYP7B1-mediated metabolism of some androgen receptor ligands, indicating that CYP7B1 can be involved also in the regulation of androgenic signaling. CYP7B1 substrates and metabolites were found to exert androgenic effects in a cell line-specific manner. Furthermore, cell line differences were observed in the expression pattern for androgen receptor comodulators. This thesis reports that 1α,25-dihydroxyvitamin D3 alters the gene expression and enzyme activity of CYP21A2 and CYP17A1 leading to suppressed production of aldosterone, dehydroepiandrosterone and androstenedione in adrenocortical cells. These are novel findings on vitamin D action. A mechanism is reported for the vitamin D-mediated regulation of the CYP21A2 gene. Data indicate that vitamin D receptor interacting repressor (VDIR) and Williams syndrome transcription factor (WSTF) are key comodulators in this novel vitamin D receptor (VDR)-mediated mechanism. Furthermore, the results indicate that altered expression levels of VDIR and WSTF can shift the suppressing effect of vitamin D to a stimulatory effect. Also, epigenetic components were found to be involved in the effects of vitamin D on CYP21A2 transcriptional rate. In addition, a functional vitamin D response element was identified in the CYP21A2 promoter. This study also reports that 1α,25-dihydroxyvitamin D3 affects sex hormone production in a tissue-specific way. Gene expression and enzyme activity of aromatase were found to be downregulated in cells derived from breast, but not in cells derived from prostate and adrenal cortex. The production of estradiol and dihydrotestosterone was altered in a tissue-selective manner following vitamin D treatment. These findings are of importance for the discussion on vitamin D as a potential anti-breast cancer agent.

Lymphomas are neoplasms of the human immune system and can be divided into two categories, Hodgkin’s lymphoma (HL) and non-Hodgkin lymphoma (NHL). Anaplastic large cell lymphoma (ALCL) is a form of NHL that shares a common distinctive feature with HL, the overexpression CD30. The expression of cytokine receptor CD30 is restricted to proliferating B and T lymphocytes in healthy individuals while its overexpression is associated with several lymphoproliferative diseases such as ALCL and HL. The activation of CD30 via ligand or antibodies triggers various cellular responses ranging from apoptosis to cell proliferation and it is thought that the variable cellular response to CD30 activation may be due to cell surface levels of CD30. The human CD30 gene is regulated at the transcriptional level and previous studies characterising its promoter have identified several factors that regulate the expression this gene. However none of these identified factors explain for the high levels of CD30 observed in HL and ALCL. Therefore this study focused on the identification and functional analysis of transcriptionally active regions located up or downstream of the CD30 promoter region. The first aim for this study was to identify and characterise regions within the human CD30 gene that are involved in its transcriptional regulation. Phylogenetic footprinting identified several regions downstream of the CD30 promoter that displayed high levels of sequence homology indicating potential functional significance. Validation of these regions through two in vivo approaches, DNase 1 hypersensitivity assay and chromatin accessibility studies localised potential transcriptionally active regions to intron 1 of the CD30 gene.

Plusieurs lymphomes à cellules B présentent des anomalies génétiques qui sont importantes pour déterminer leurs caractéristiques biologiques et peuvent être utiles pour le diagnostic. Les types les plus courants sont le lymphome folliculaire et le lymphome diffus à grandes cellules B (LDGCB), qui représentent à eux deux plus de 60 % de tous les lymphomes. Les LDGCB sont agressifs mais peuvent être traités par chimiothérapie à agents multiples. Cependant, les gènes suppresseurs de tumeur (GST) potentiellement responsables de la lymphomagenèse ne sont pas tous connus. Le rationnel de ce projet reposait sur des données non publiées du projet translationnel GHEDI (déchiffrer l'hétérogénéité génétique du lymphome diffus à grandes cellules B à l'ère du rituximab). Une hybridation génomique comparative (CGH) (puce Agilent 180 K) a été réalisée sur une série de 202 LDGCB de la série GHEDI et 40 % des délétions de la région 6q21 ont été identifiées, dont la région minimale commune délétée qui contient le gène HACE1. Par ailleurs, l'analyse transcriptomique a montré une corrélation significative entre le nombre de copies du gène et le niveau d'expression. Le gène HACE1, situé sur le chromosome 6q, code pour une ubiquitine ligase E3 et est régulé négativement chez l'homme dans les tumeurs, y compris les neuroblastomes et les lymphomes à cellules tueuses naturelles (NK). Il a été montré que le gène HACE1 ubiquityle Rac1, une protéine impliquée dans la prolifération cellulaire et la progression G2/M du cycle cellulaire. La fonction du gène HACE1 et les facteurs impliqués dans sa régulation transcriptionnelle sont en grande partie inconnus dans le contexte des lymphomes à cellules B. Dans cette étude, nous avons examiné si le gène HACE1 était un gène candidat dans la région génomique 6q impliqué dans la lymphomagenèse des LDGCB et plus largement dans les lymphomes B. Nous avons déterminé la fréquence de l'inactivation du gène HACE1 dans le lymphome à cellules B et analysé les mécanismes impliqués dans son extinction. / Several B-cell lymphomas have characteristic genetic abnormalities that are important in determining their biologic features and can be useful in differential diagnosis. Historically, classical Hodgkin lymphomas have been distinguished from non-Hodgkin lymphomas (NHL). The most common types are follicular lymphoma and diffuse large B-cell lymphoma (DLBCL), which together make up more than 60% of all lymphomas. DBCL are aggressive but potentially curable with multi-agent chemotherapy. However the putative tumor suppressor genes (TSG) responsible for lymphomagenesis still remain unknown. The rational of this project was based on unpublished data from the translational project GHEDI (Deciphering the Genetic Heterogeneity of Diffuse large B-cell lymphoma in the rituximab era). Array comparative genomic hybridization (aCGH) (Agilent 180 K) was performed in a series of 202 DLBCL and found 40% of deletions of 6q21 region, whose minimal commune deleted region (MCR) contains HACE1 gene. Furthermore, transcriptomic analysis showed a significant correlation between gene copy number and expression level. HACE1, located on chromosome 6q, encodes an E3 ubiquitin ligase and is downregulated in human tumors such as neuroblastomas and natural killer (NK) lymphomas. HACE1 has been shown to ubiquitylate Rac1, a protein involved in cell proliferation and G2/M cell cycle progression. The function of HACE1 and the factors involved in its transcriptional regulation are largely unknown in the context of B-cell lymphomas. In this study, we investigated whether HACE1 is a candidate gene in the 6q genomic region involved in DLBCL lymphomagenesis. We determined the frequency of HACE1 inactivation in B-cell lymphoma and analyzed the mechanisms involved in its silencing. We show, by RT-qPCR, that HACE1 gene is constitutively expressed in normal lymph nodes and in normal B-cells isolated from peripheral blood, contrasting with a strong downregulation of its expression in more than 70% (77/111) of B-cell lymphoma cases and in four tested B-Lymphoma cell lines. HACE1 gene copy number was assessed by quantitative multiplex PCR of short fluorescent fragments (QMPSF) and array for comparative genomic hybridization (aCGH) in 91 DLBCL cases.

Le virus de la maladie de Marek (MDV) est un virus oncogène responsable des lymphomes T chez les poulets. L´infection par ce virus est divisée en une phase lytique dépendante de l´expression du gène très précoce ICP4 et une phase latente, caractérisée par l´expression de l’ARN long non codant LAT localisé en antisens. Nous avons montré que l’expression différentielle des miARN du cluster mdv1-miR-M8-M10 était directement corrélée à l’épissage alternatif de l’intron 1 du LAT et plus particulièrement à la biogenèse par le splicéosome du premier mirtron viral. La présence du mirtron mdv1-miR-M6 au milieu du cluster est associée à une cinétique d’expression des miARN. En parallèle, nous avons identifié deux promoteurs alternatifs de type Sp1, quatre signaux poly-A et trois exons associés à la régulation de la transcription du transcrit ICP4. Nous avons prédits cinq isoformes potentielles pour la protéine ICP4 et avons pu observer par immunodétection que la protéine était exprimée principalement dans le cytoplasme des cellules infectées en phase lytique ou de réactivation. / The Marek disease virus (MDV) is an oncogenic herpesvirus responsible of T-cell lymphoma in chicken. MDV infections are divided into a lytic phase, depending on the expression of immediate early gene like ICP4, and a latent phase characterized by the expression of the long non-coding RNA LAT localized in antisense. In this study, we have shown the differential expression of the cluster of miRNA mdv1-miR-M8-M10 was directly correlated with the alternative splicing of LAT’s intron 1 and more specifically with the first viral mirtron biogenesis by the spliceosome. The location of the mirtron mdv1-miR-M6 inside of the cluster is associated with a two-step biogenesis of the miARN of the cluster. On the other hand, we have identified a dual promoter that responded to Sp1, four poly-A signals and three exons that are responsible of transcriptional regulation of ICP4 transcript. We also have predicted five potential isoproteines for ICP4 and were able to observe by immunodetection that ICP4 was mainly expressed in the cytoplasm of infected cells during the lytic phase or the reactivation one.

Les facteurs de transcription de la famille p53 dans l’atrophie musculaire - Implications dans la Sclérose Latérale Amyotrophique et la cachéxie. L’atrophie musculaire est un symptôme dangereux retrouvé dans plusieurs maladies. Dans la sclérose latérale amyotrophique (SLA), une maladie neuromusculaire rare, ainsi que dans le cancer (phénomène de cachexie), l’atrophie musculaire cause le décès des patients. Les facteurs de transcription de la famille p53 sont impliqués dans de nombreux processus cellulaires, faisant face à des situations de « stress » pour les cellules. Notamment, ils peuvent induire la mort cellulaire ou promouvoir la différentiation.Nous avons constaté, à partir de modèles cellulaire et animaux de SLA et cachéxie cancéreuse, que des membres de la famille p53 sont activés dans les muscles atrophiques. Cette activation entraine l’expression de gènes cibles impliqués dans la mort cellulaire. De manière intéressante, TAp73, mais surtout TAp63, sont capables d’activer la transcription d’un effecteur de l’atrophie musculaire appelé MuRF1, démontrant que la famille p53 peut participer activement à l’atrophie en induisant la dégradation des fibres musculaires.De plus, nous avons utilisé nos modèles animaux pour identifier une nouvelle approche contre l’atrophie musculaire. Ainsi, nous avons identifié un dérivé de tocophérol avec des propriétés thérapeutiques intéressantes. / The p53 family of transcription factors in muscular atrophy - Involvements in Amyotrophic Lateral Sclerosis and cachexia Muscular atrophy is a dangerous condition found in several diseases. In amyotrophic lateral sclerosis (ALS), a rare neuromuscular disease, as well as in cancer (phenomenon of cachexia), muscular atrophy can be fatal to patients.The transcription factors from the p53 family are involved in several cellular processes, facing cellular “stress” situations. Most notably, they can induce dell death or promote differentiation.We found, using cellular and mouse models of ALS and cachexia, that members of the p53 family are induced during muscular atrophy. This induction leads to the expression of canonnic target genes involved in cell death. Interestingly, TAp73, but especially TAp63, are able to activate the transcription of an effector or muscular atrophy called MuRF1. This proves that the p53 family cand participate in muscular atrophy by promoting the breakdown of muscle fibres.In addition, we used our mouse models to identifiy a new approach agains muscular atrophy.Indeed, we identified a derivative of tocopherol with interesting therapeutical proprieties.

Malgré l'amélioration des traitements, environ 20% des patients atteints de leucémie aigue lymphoblastiques (LAL) rechutent dans la moelle osseuse ou dans des sites extra-médullaires tels que les ovaires et les testicules, ce qui est particulièrement fréquent dans les rechutes tardives de LAL-B présentant un remaniement ETV6/RUNX1. Les travaux réalisés par Virginie Gandemer en 2007, ont montré que l'expression de CD9 permettait de distinguer les leucémies ETV6/RUNX1 des autres types de leucémie. Le gène CD9 code pour une protéine de la famille des tétraspanines dont l'expression a été corrélée avec le risque métastatique et la survie des patients. Par ailleurs il a été démontré que la protéine CD9 était impliquée dans le homing et la prise de greffe des cellules souches hématopoïétiques et leucémiques. Nous avons donc émis l'hypothèse qu'à travers ses propriétés fonctionnelles sur la migration et le homing, CD9 pourrait être un acteur clé des rechutes de LAL-B. Le but de ce travail de thèse était donc premièrement de déterminer le mode de régulation de CD9 dans les LAL-B ETV6/RUNX1 et deuxièmement de déterminer les effets de l'expression de CD9 sur la motilité et la prise de greffe des LAL-B. Les analyses préalablement réalisées au laboratoire avaient suggéré que CD9 pouvait être régulé par des miARNs. Nous avons identifié un cluster de 3 miARNs potentiellement impliqués dans la régulation de CD9 dans les LAL-B ETV6/RUNX1. Ces résultats doivent cependant être complétés par d'autres analyses fonctionnellles afin d'être confirmés. Nous avons étudié le rôle de la protéine CD9 dans la dissémination des cellules de LAL-B. Nous avons démontré que CD9 était un régulateur potentiel de l'adhésion et un nouveau facteur impliqué dans la migration et le homing dépendants de CXCR4 en favorisant l'activation de RAC1 et les réarrangements de l'actine en réponse au CXCL12. Enfin, nous avons décrit pour la première fois l'influence de CD9 sur la migration et le homing dans les testicules via RAC1. Nos résultats montrent donc que CD9 favorise la dissémination des cellules de LAL-B dans les testicules et suggèrent que cette protéine pourrait constituer un acteur majeur des rechutes tardives de LAL-B dont les mécanismes d'apparitions sont peu connus. / Despite improvements in survival rates, approximately 20% of children suffering from acute lymphoblastic leukemia (B-ALL) present relapses from bone marrow or from B-extramedullary sites, such as the testes or ovaries, particularly in cases of late relapse of ETV6/RUNX1-ALL. Virgine Gandemer showed in 2007, that the expression of CD9, a protein from the tetraspanin superfamily, can be used to distinguish ETV6/RUNX1 lymphoblastic leukemia from other types of ALL. CD9 expression has been correlated with the risk of metastasis and is associated with a poor clinical outcome in various types of cancer. Moreover CD9 has been implicated in hematopoietic and leukemic stem cell homing. We hypothesized, that CD9 protein, through its functional properties on migration and homing, could be a key actor of B-ALL relapses. The purpose of our study was then to investigate, first the transcriptional regulation of CD9 in ETV6/RUNX1 B-ALL and secondly, the effect of CD9 expression on motility and engrafment of B lymphoblasts. The analysis of CD9 transcriptional regulation previously made in the team, suggested that it could be regulated by miRNAs. We identified a cluster of 3 miRNAs potentially implicated in the regulation of CD9 expression in ETV6/RUNX1 B-ALL. This result has to be confirmd by more functional analysis. We investigated the role of CD9 in the dissemination of B-ALL. We identified CD9 as a potential regulator of B-ALL cell adhesion and a new factor involved in CXCR4-mediated migration and homing, through the promotion of actin rearrangement in response to CXCL12. We also characterized the effect of CD9 protein expression on RAC1 activation, which had an impact on blast migration and engraftment. Finally, we described, for the first time, the influence of CD9, mediated by RAC1 signaling, on B-cell chemotactic migration and homing in the testis. Our work provides evidence for an impact of CD9 on the ability of pre-B leukemic cells to disseminate to testes, through its effects on migration and homing, and suggests that CD9 may be a key player in late relapses of B-ALL, which are currently poorly understood.

Made available in DSpace on 2014-06-12T15:50:15Z (GMT). No. of bitstreams: 2 arquivo1959_1.pdf: 2352925 bytes, checksum: 90760b286db4ed0dcc12ae48554413a9 (MD5) license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2008 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Estudos recentes têm demonstrado que as redes biológicas apresentam características nãoaleatórias, dentre as quais destacamos a arquitetura modular. Neste trabalho, estamos interessados na organização modular das redes de regulação transcricional (RRT), que modelizam as interações entre genes e proteínas que controlam a sua expressão no nível transcricional. Compreender os mecanismos de regulação transcricional é crucial para se explicar a diversidade morfológica e funcional das células. Nós nos propomos a abordar o problema da identificação de módulos regulatórios transcricionais, i.e. grupos de genes co-regulados e seus reguladores, com ênfase no aspecto computacional. Uma distinção importante deste trabalho é que estamos também interessados em estudar o aspecto evolutivo dos módulos transcricionais. Do ponto de vista biológico, a abordagem proposta está fundamentada em três premissas principais: (i) genes co-regulados são controlados por proteínas regulatórias comuns (fatores de transcrição FTs) e, portanto, eles devem apresentar padrões de sequência (motifs) comuns nas suas regiões regulatórias, que correspondem aos sítios de ligação desses FTs, (ii) genes co-regulados respondem coordenadamente a certas condições ambientais e de desenvolvimento e, logo, devem ser co-expressos sob essas condições, e (iii) uma vez que módulos transcricionais são presumivelmente responsáveis por funções biológicas importantes, eles estão sujeitos a uma maior pressão seletiva e, consequentemente, devem ser evolutivamente conservados. Nós definimos, portanto, o conceito de metamódulo regulatório transcricional (MMRT) como grupos de genes compartilhando motifs e exibindo um comportamento de expressão coerente em contextos específicos consistentemente em várias espécies e propomos modelos probabilísticos para descrever o comportamento modular em termos do compartilhamento de elementos regulatórios (motifs), da co-expressão e da conservação evolutiva das associações funcionais entre os genes com base em dados diversos tais como dados de sequência, de expressão e dados filogenéticos

O iodo em excesso promove o efeito Wolff-Chaikoff. Oligominerais já foram descritos como potenciais reguladores da expressão de proteínas. Tornou-se interessante avaliar se o iodo interferiria com a expressão do mRNA da NIS, em curtos períodos de tempo. Foram realizados, em ratos e células (de 30 min24h), estudos de expressão, comprimento de cauda poli-A e recrutamento para polissomos, do mRNA de NIS. Observou-se, in vivo e in vitro, que o excesso de iodo promoveu diminuição da expressão e do comprimento da cauda poli-A do mRNA de NIS, em todos os períodos estudados, além de promover menor recrutamento deste mRNA para os polissomos. A diminuição da cauda poli-A do mRNA de NIS pode ter aumentado sua instabilidade/degradação e também ter sido responsável por uma menor eficiência de tradução deste transcrito. Conclui-se que: (a) o iodo regula pós-transcricionalmente a expressão gênica da NIS, sendo fundamental nos processos que norteiam o efeito Wolff-Chaikoff e (b) oligoelementos têm relevância na regulação da expressão de proteínas relacionadas ao seu transporte. / Iodide in excess exerts the Wolff-Chaikoff effect. It is described that some minerals can regulate the expression of proteins. This study aimed to investigate if the iodide could modify the expression of NIS mRNA, in short periods of time. Rats and cells, divided in time-groups of 30 min up to 24h, were used in studies of expression, poly-A tale length and polysomal profile of NIS mRNA. Both in vivo and in vitro studies showed that the iodide treatment promoted a reduction in the expression and the poly-A length of NIS mRNA, in all time-groups, and decreased its recruitment to the polysomes. It is possible that the reduction of NIS mRNA poly-A tale length has increased the instability/degradation of this transcript, and impaired the translation efficiency of it. Concluding: a) the iodine exerts a post-transcriptional regulation of NIS mRNA expression, being essencial in the processes that guide the Wollf-Chaikoff effect; b) the oligoelements have an extremely important role in the expression regulation of proteins related to their transport.

O desenvolvimento embrionário é o resultado de uma sequência controlada de eventos modulados por sinais ambientais e mecanismos intracelulares. Em Hymenoptera, esse processo tem um caráter especial devido ao sistema de determinação do sexo (Haplodiploide). Neste sistema, os ovos fecundados se desenvolvem em fêmeas (diploides) e os ovos não fecundados em machos (haploides). Assim, eventos importantes, como a ativação do ovo e transição materno-zigótica, eventos iniciais da embriogênese, são elementos-chave para compreender o desenvolvimento de ambos os tipos de embriões. Ativação do ovo é um evento complexo acionado em resposta a estímulos externos, necessários para o início da embriogênese. Em abelhas a ativação ovo ocorre independentemente da fecundação e parece ser desencadeado durante a passagem pelo trato reprodutivo da mãe. Além disso, se o ovócito não for fecundado ele irá se desenvolver em um organismo haploide. No entanto, se o ovo recebe o espermatozóide até 30 minutos depois da ativação, o ovo se desenvolve em um organismo diploide. Em Drosophila, a ativação do ovo é também idependente da fecundação. O estímulo inicial que desencadeia o desenvolvimento é devido tensões mecânicas sofridas pelo ovócito durante a ovulação pela passagem através do trato reprodutivo. Neste modelo, o primeiro sinal de ativação inclui a ativação da via dependente de cálcio. Moléculas maternas que são incorporados no ovócito durante ovogênese, atuam durante a ativação do ovo, bem como no início da embriogênese. Os eventos iniciais da embriogênese também são caracterizados pela ausência de altos níveis de transcrição zigótica. As moléculas depositadas atuam na ativação do ovo, quebrando a dormência da divisão celular permitindo a ocorrência do início do desenvolvimento embrionário. Mas, o embrião em desenvolvimento gradualmente degrada e substitui essas moléculas herdadas da mãe, em um processo conhecido como transição materno-zigótica. Nosso principal objetivo foi o entendimento da comunicação entre as moléculas herdadas e as recém produzidas durante os primeiros passos do desenvolvimento de Apis mellifera. Para alcançar nosso objetivo, 16 bibliotecas de RNAseq (mRNA e miRNA) foram construídas utilizando amostras de RNA total de embriões diploides e haploides de diferentes idades e ovócitos maduros. A análise do transcriptoma mostrou que existem genes diferencialmente expressos entre os dois tipos de embriões já em 1 h de desenvolvimento. Além disso, nossa análise permitiu a identificação de mRNAs e miRNAs maternos e zigóticos, além de processos com que estas moléculas se relacionam. As análises mostraram também que um mesmo miRNA pode atingir diferentes mRNAs em cada tipo de embrião, na mesma fase de desenvolvimento. Além disso, um mesmo gene pode ser diferentemente regulado nos dois tipos de embriões. Por exemplo, broad/GB48272, que é classificado como materno em embriões dipoides é regulado por quatro miRNAs diferentes e em embriões haploides é classificado como zigótico, regulado por apenas um miRNA. Análise das bibliotecas de RNAseq e hibridação in situ mostrou o padrão de expressão de zelda em embriões jovens de abelhas. Zelda é um ativador chave do genoma zigótico em Drosophila e regula eventos importantes na embriogênese se ligando a um motivo conservado, TAGteam. Em A. mellifera, encontramos um motivo TAGteam putativo que tem sido relacionado à transcrição zigótica precoce. Além disso, a hibridização in situ e PCR mostraram três primiRNAs (ame-mir-375-3p, ame-mir-34-5p e ame-mir-263b-5p) que se expressam durante a clivagem. A presença de pri-miRNAs evidenciou a início da transcrição zigótica durante a clivagem. Em suma, podemos dizer que este é o primeiro trabalho em Apis mellifera a descrever os eventos de iniciais do desenvolvimento embrionário comparando embriões haploides e diploides usando os recentes protocolos de bioinformática e os avanços da biologia molecular. / Embryonic development is the result of a precisely controlled sequence of events modulated by environmental signals and intracellular mechanisms. In Hymenoptera, this process takes a special character due the sex-determination system (haplodiploidy). In this system, fertilized eggs develop in females (diploid) and unfertilized eggs in males (haploid). Thus, important events such as egg activation and maternal-zygotic transition, events of the early embryogenesis are key elements to understand the development of both types of embryos. Egg activation is a complex event triggered in response to external stimuli and necessary for the onset of embryogenesis. In honeybees egg activation occurs independently of fertilization and seems to be triggered during the passage through mother\'s reproductive tract. Furthermore, if the egg is not fertilized it will develop into haploid organism. However, if the egg receives the sperm up to 30min after activation, this egg develops into a diploid organism. In Drosophila, the egg activation is also fertilization independent. Initial stimulus that triggers the development is due mechanical stresses suffered by the egg during ovulation and passage through the reproductive tract. In this model, the first activation signal includes activation of calciumdependent pathway. Maternal molecules that are incorporated into the oocyte during ovogenesis, act during egg activation, as well as in early embryogenesis. Early embryogenesis events are also characterized by absence of high levels of zygotic transcription. The deposited molecules drive egg activation, breaking cell division dormancy permitting the beginning of embryonic development. But, the developing embryo gradually degrades and substitutes these mother-inherited molecules, in a process known as mother-to-zygote transition. Our main objective was the understanding of the deep crosstalk among the inherited molecules and the newly ones produced during the first steps of Apis mellifera embryogenesis. To achieve our objective 16 deep sequenced RNA (mRNA, miRNA) libraries were constructed using different age diploid and haploid embryos, and mature oocytes. Genome-wide transcriptome analysis was performed and interactive regulatory networks were constructed. Our analysis permitted the identification of maternal and zygotic mRNAs and miRNAs and related processes. Based on expression profiles of mRNAs and miRNAs in mature oocytes and haploid and diploid embryos of 2, 6 and 18-24 h of development, we constructed integrative regulatory networks (miRNA:mRNA) showing that the same miRNA could target different mRNAs in each type of embryo, in the same phase of development. As example we cite broad/GB48272, which is classified as maternal in diploid embryos and regulated by four different miRNAs. However, in haploid embryos it is zygotic and regulated by only one miRNA. Analysis of RNAseq and in situ hybridization showed the expression pattern of zelda in early honeybee embryos. Zelda is a key activator of Drosophila early zygotic genome and regulates important events in early embryogenesis binding to TAGteam motif. In A. mellifera, we found a putative TAGteam motif that has been implicated in early zygotic transcription. Moreover, in situ hybridization and PCR assay showed three pri-miRNAs (ame-mir-375-3p, ame-mir-34-5p and ame-mir-263b-5p) expressed during cleavage. The presence of pri-miRNAs is the first evidence of early zygotic transcription during cleavage. In short, we could say that this is the first work on Apis mellifera describing the early embryonic developmental events comparing haploid and diploid embryos using modern bioinformatics tools and advanced molecular analysis.

The process of specific gene transcription by RNA polymerase II (Pol II) is initiated by the<p>binding of specific transcription factors to DNA. A global understanding of the mechanisms of gene<p>transcriptional regulation of Saccharomyces cerevisiae goes through the description of the targets and<p>the behavior of those transcription factors.<p>The GATA factors are specific transcription factors intervening in the regulation of Nitrogen<p>Catabolite Repression (NCR)-sensitive genes, a mechanism encompassing the transcriptional<p>regulations leading to the preferential use of good nitrogen sources of the growth medium of yeast in<p>the presence of less good nitrogen sources. Those 4 GATA factors involved in NCR comprise 2<p>activators (Gat1 and Gln3) and 2 repressors (Gzf3 and Dal80).<p>Generally speaking, the promoters of genes have always been described like the main place for<p>the integration of the transcription regulation signals relayed by the general and specific transcription<p>factors and the chromatin remodeling factors. Furthermore, the GATA factors have been described as<p>integrating the external signals of nitrogen availability thanks to their specific DNA binding to<p>consensus GATA sequences in the promoter of NCR-sensitive genes. The results presented here<p>introduce many nuances to the model, notably implying new proteins but also new regions in the<p>regulation process of the NCR-sensitive gene regulation. Indeed, the first goal of this work is to<p>discover and understand the mechanisms of NCR-sensitive gene regulation that will explain the<p>variations in their expression levels in the presence of various nitrogen sources and their dependency<p>towards the GATA factors.<p>Strikingly, it appeared that GATA factor positioning was not limited to the promoter, but<p>occurred also in the transcribed region. It seems that the transcription factors may have been driven<p>by the general transcription machinery (Pol II). The binding of a chromatin remodeling complex, RSC,<p>has also been demonstrated in the coding region of NCR-sensitive genes. Moreover, the binding of the<p>histone acetyltransferase complex, SAGA, recruited by the GATA activators, was highlighted along<p>NCR-sensitive genes. The SAGA complex was also implied in their transcriptional regulation.<p>Finally, a ChIP-sequencing experiment revealed an unsuspected number and diversification of<p>targets of the GATA factors in yeast, which were not limited to NCR-sensitive genes.<p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished